Delivery Order SPE2DR25D3404-SPE2DR26F5V8D
- Not listed
- The Defense Logistics Agency awarded a $9,829.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract is a non-set-aside award with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,351.00 delivery order to AmerisourceBergen Drug Corp for Ferumoxytol 510 mg/17 mL vials on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,894.39 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on November 18, 2025, with completion targeted for November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through DLA's pharmaceutical procurement process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $13,988.34 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order represents a relatively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a firm fixed price ceiling value of $4,988.61. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of November 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $24,546.62 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on October 8, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $2,739.35 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials. This is a firm fixed price contract with an ultimate completion date of November 14, 2025, and represents a small-value delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract was awarded non-competitively through this existing indefinite delivery contract,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $5,165.40. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply vehicle with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D3404Indefinite Delivery Contract
- SPE2DR25D3404-SPE2DR26F5V8DDelivery Order
The Defense Logistics Agency awarded a $5,532.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which is not set aside for any specific business category, represents a competitively awarded transaction with an ultimate completion date of January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's parent organization is Cencora, Inc., which does business as AmerisourceBergen. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The parent IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related healthcare commodities to support military healthcare programs worldwide. The contract vehicle facilitates supply to the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems, demonstrating the strategic importance of pharmaceutical distribution contractors within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/19/26 |